pharmadrug’s sairiyo therapuetics provides strategic plans to advance pd-001 (patented reformulated cepharanthine) for viral infectious diseases
Toronto, Ontario--(Newsfile Corp. - August 28, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC: LMLLF) ("PharmaDrug" or the "Company"), a specialty...